...
首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Redo in aortic homograft replacement: transcatheter aortic valve as a valid alternative to surgical replacement.
【24h】

Redo in aortic homograft replacement: transcatheter aortic valve as a valid alternative to surgical replacement.

机译:重做主动脉同种异体移植:经导管主动脉瓣膜可作为手术替代的有效替代方法。

获取原文
获取原文并翻译 | 示例

摘要

Reintervention in patients who have undergone an aortic homograft valve replacement remains a technical challenge. We report the case of a patient with multiple aortic valve replacements having an aortic homograft with severe calcific stenosis who successfully underwent transcatheter aortic valve insertion (TAVI). A 48-year-old woman was referred to our hospital with symptoms of ingravescent severe dyspnea. Fifteen years earlier, she had undergone placement of a 21-mm aortic valve Bravo 400 stentless xenograft (Cryolife International, Atlanta, Ga). Four years later, she underwent a valve replacement with a 21-mm mechanical prosthesis (Carbomedics, Austin, Tex) for valve degeneration, and subsequently, she received a homograft for aortic valve endocarditis.
机译:对经历主动脉同种瓣膜置换术的患者进行再次干预仍然是一项技术挑战。我们报告了多例主动脉瓣置换术患者的主动脉同种移植伴严重钙化狭窄的病例,该患者成功接受了经导管主动脉瓣插入术(TAVI)。一名48岁的妇女因症状轻度重度呼吸困难被转诊到我们医院。 15年前,她接受了21毫米主动脉瓣Bravo 400无支架异种移植物的植入(Cryolife International,亚特兰大,乔治亚州)。四年后,她用21毫米的机械假体(Carbomedics,奥斯汀,得克萨斯州)进行了瓣膜置换术,以治疗瓣膜变性,随后,她接受了同种异体移植治疗主动脉瓣膜心内膜炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号